Cosmos Health Inc. (COSM) intrinsic value & 10-year financials
Cosmos Health Inc. (COSM) has a Graham intrinsic value of $1.99 per share. At $0.33 on Oct 17, 2026, the stock trades 83% below that value. Over the last 10 fiscal years revenue grew 28.7% a year to $65.3M, with an average return on invested capital of -37.4%.
- Graham intrinsic value
- $1.99
- Share price (Oct 17, 2026)
- $0.33
- Price vs Graham value
- 83% below
- Market cap
- $10.0M
- Revenue (FY2025)
- $65.3M
- Revenue growth (10-yr CAGR)
- 28.7%
- ROIC (10-yr avg)
- -37.4%
- Free cash flow (FY2025)
- -$8.5M
COSM 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $65.3M | -$19.1M | -$0.63 | -$8.5M | -25.6% | -65.9% |
| FY2024 | $54.4M | -$16.2M | -$1.17 | -$8.1M | -28.6% | -44.2% |
| FY2023 | $53.4M | -$18.5M | -$2.15 | -$16.9M | -40.9% | -66.3% |
| FY2022 | $50.3M | -$13.8M | -$33.16 | -$14.9M | -14.8% | -49.7% |
| FY2021 | $56.2M | -$8.0M | -$0.95 | -$7.7M | -8.1% | -370.5% |
| FY2020 | $55.4M | $820.8K | $0.06 | -$11.6M | 4.9% | -45.5% |
| FY2019 | $39.7M | -$3.3M | -$0.25 | — | -0.6% | 6.4% |
| FY2018 | $37.1M | -$9.1M | -$0.68 | -$2.1M | -3.3% | 46.8% |
| FY2017 | $30.0M | -$6.2M | $677,206.00 | -$8.8M | -16.2% | 203.8% |
| FY2016 | $6.8M | -$601.0K | $0.00 | -$2.1M | -3.0% | 11.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Cosmos Health Inc. is a consistent compounder, expanding top-line revenue at 28.7% annually over the past decade.
Cosmos Health Inc. has historically struggled to out-earn its cost of capital, averaging just -20.9% ROIC.
Over the decade, Cosmos Health Inc. shows that management has aggressively returned capital to shareholders by retiring 75.9% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Cosmos Health Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.99 per share.